A genetic test may predict which weight loss drugs work best for patients News Health & Medicine A genetic test may predict which weight loss drugs work best for patients Clinical trials show people with different “genetic scores”..."> A genetic test may predict which weight loss drugs work best for patients News Health & Medicine A genetic test may predict which weight loss drugs work best for patients Clinical trials show people with different “genetic scores”..." /> A genetic test may predict which weight loss drugs work best for patients News Health & Medicine A genetic test may predict which weight loss drugs work best for patients Clinical trials show people with different “genetic scores”..." />

Passa a Pro

A genetic test may predict which weight loss drugs work best for patients

News

Health & Medicine

A genetic test may predict which weight loss drugs work best for patients

Clinical trials show people with different “genetic scores” lose more weight on specific drugs

Genetics tests may help predict whether GLP-1 drugs, such as semaglutide and liraglutide, or a different type of medication may work better for some people.

© Obesity Action Coalition

By Tina Hesman Saey
June 13, 2025 at 9:00 am

People trying to lose weight often count calories, carbs, steps and reps and watch the scales. Soon, they may have another number to consider: a genetic score indicating how many calories a person needs to feel full during a meal.
This score may help predict whether someone will lose more weight on the drugs liraglutide or phentermine-topiramate, researchers report June 6 in Cell Metabolism. A separate study, posted to medRXiv.org in November, suggests that individuals with a higher genetic propensity for obesity benefit less from semaglutide compared to those with a lower genetic predisposition.

Sign up for our newsletter

We summarize the week's scientific breakthroughs every Thursday.
#genetic #test #predict #which #weight
A genetic test may predict which weight loss drugs work best for patients
News Health & Medicine A genetic test may predict which weight loss drugs work best for patients Clinical trials show people with different “genetic scores” lose more weight on specific drugs Genetics tests may help predict whether GLP-1 drugs, such as semaglutide and liraglutide, or a different type of medication may work better for some people. © Obesity Action Coalition By Tina Hesman Saey June 13, 2025 at 9:00 am People trying to lose weight often count calories, carbs, steps and reps and watch the scales. Soon, they may have another number to consider: a genetic score indicating how many calories a person needs to feel full during a meal. This score may help predict whether someone will lose more weight on the drugs liraglutide or phentermine-topiramate, researchers report June 6 in Cell Metabolism. A separate study, posted to medRXiv.org in November, suggests that individuals with a higher genetic propensity for obesity benefit less from semaglutide compared to those with a lower genetic predisposition. Sign up for our newsletter We summarize the week's scientific breakthroughs every Thursday. #genetic #test #predict #which #weight
WWW.SCIENCENEWS.ORG
A genetic test may predict which weight loss drugs work best for patients
News Health & Medicine A genetic test may predict which weight loss drugs work best for patients Clinical trials show people with different “genetic scores” lose more weight on specific drugs Genetics tests may help predict whether GLP-1 drugs, such as semaglutide and liraglutide, or a different type of medication may work better for some people. © Obesity Action Coalition By Tina Hesman Saey June 13, 2025 at 9:00 am People trying to lose weight often count calories, carbs, steps and reps and watch the scales. Soon, they may have another number to consider: a genetic score indicating how many calories a person needs to feel full during a meal. This score may help predict whether someone will lose more weight on the drugs liraglutide or phentermine-topiramate, researchers report June 6 in Cell Metabolism. A separate study, posted to medRXiv.org in November, suggests that individuals with a higher genetic propensity for obesity benefit less from semaglutide compared to those with a lower genetic predisposition. Sign up for our newsletter We summarize the week's scientific breakthroughs every Thursday.